Skip to Content

250 IP188 (Naproxen 250 mg)

Pill imprint 250 IP188 has been identified as Naproxen 250 mg.

Naproxen is used in the treatment of back pain; ankylosing spondylitis; bursitis; tendonitis; chronic myofascial pain (and more), and belongs to the drug class nonsteroidal anti-inflammatory agents. Risk cannot be ruled out during pregnancy. Naproxen 250 mg is not a controlled substance under the Controlled Substance Act (CSA).

Naproxen 250 mg 250 IP188
Naproxen 250 mg 250 IP188
Naproxen 250 mg 250 IP188
250 IP188
250 mg
Rx and/or OTC
Drug Class:
Nonsteroidal anti-inflammatory agents
Pregnancy Category:
C - Risk cannot be ruled out
CSA Schedule:
Not a controlled drug
Akyma Pharmaceuticals
National Drug Code (NDC):
Other Manufacturers / Repackagers:
NDC CodeManufacturer / Repackager
00904-6069 Major Pharmaceuticals
53746-0188 Amneal Pharmaceuticals LLC
68462-0188 Glenmark Pharmaceuticals Inc., USA
63739-0180 McKesson Packaging Services
55111-0366 Dr. Reddy's Laboratories Inc.
65162-0188 Amneal Pharmaceuticals LLC
54569-3758 A-S Medication Solutions, LLC (repackager)
55289-0445 PDRX Pharmaceuticals Inc (repackager)

Note: Inactive ingredients may vary.

View Details Print Imprint Search

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2016, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.